Skip to content

Effect of Rasamanikya (A Herbomineral formulation) in Psoriasis

Pharmaceutical standardization of Rasamanikya prepared by two different Shodhana media of Haratala & their comparative clinical efficacy in the management of Eka kushtha (Psoriasis)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011151
Enrollment
60
Registered
2018-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients having signs and symptoms of Eka Kushtha(Psoriasis)

Interventions

Intervention1: Rasamanikya prepared by Kushmanda Swarasa Shodhita Haratala (RKH): RKH (125mg) along with Guduchi Ghana (375mg) twice daily in capsule form after meal with Madhu for duration of 8 weeek

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with all forms of Ekakushtha (Psoriasis) Chronicity less than 10 years

Exclusion criteria

Exclusion criteria: 1 Age more than 60 and below 18 years. 2 Pregnant woman and planning to be pregnant within six month. 3 Lactating mothers. 4 Uncontrolled Diabetes Mellitus & Hypertension. 5 Malignant and accelerated hypertensive. 6 CVS disorders (CAD). 7 CNS disorder e.g. encephalopathy 8 Any other serious systemic illness. 9 Chronicity more than 10 years. 10 Patients who are not willing to be included in the study. 11 Cases with Asadhya Lakshana of Ekakustha

Design outcomes

Primary

MeasureTime frame
1.Marked improvement in itching and scaling and other clinical features 2 complete remission of psoriatic lesions 3 Non recurrence after the follow up periodTimepoint: 56 days

Secondary

MeasureTime frame
1 Improvement in skin texture 2 Improvement in Dermatological QOLTimepoint: 28 days

Countries

India

Contacts

Public ContactProf BJ Patgiri

IPGT and RA

patgiri124@gmail.com9426947438

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026